Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration

Many neurodegenerative diseases, including Huntington’s disease (HD) and Alzheimer’s disease (AD), occur due to an accumulation of aggregation-prone proteins, which results in neuronal death. Studies in animal and cell models show that reducing the levels of these proteins mitigates disease phenotyp...

Full description

Bibliographic Details
Main Authors: Ron Benyair, Sai Srinivas Panapakkam Giridharan, Pilar Rivero-Ríos, Junya Hasegawa, Emily Bristow, Eeva-Liisa Eskelinen, Merav D Shmueli, Vered Fishbain-Yoskovitz, Yifat Merbl, Lisa M Sharkey, Henry L. Paulson, Phyllis I Hanson, Samarjit Patnaik, Ismael Al-Ramahi, Juan Botas, Juan Marugan, Lois S. Weisman
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Autophagy Reports
Subjects:
Online Access:http://dx.doi.org/10.1080/27694127.2023.2166722
_version_ 1827818506754719744
author Ron Benyair
Sai Srinivas Panapakkam Giridharan
Pilar Rivero-Ríos
Junya Hasegawa
Emily Bristow
Eeva-Liisa Eskelinen
Merav D Shmueli
Vered Fishbain-Yoskovitz
Yifat Merbl
Lisa M Sharkey
Henry L. Paulson
Phyllis I Hanson
Samarjit Patnaik
Ismael Al-Ramahi
Juan Botas
Juan Marugan
Lois S. Weisman
author_facet Ron Benyair
Sai Srinivas Panapakkam Giridharan
Pilar Rivero-Ríos
Junya Hasegawa
Emily Bristow
Eeva-Liisa Eskelinen
Merav D Shmueli
Vered Fishbain-Yoskovitz
Yifat Merbl
Lisa M Sharkey
Henry L. Paulson
Phyllis I Hanson
Samarjit Patnaik
Ismael Al-Ramahi
Juan Botas
Juan Marugan
Lois S. Weisman
author_sort Ron Benyair
collection DOAJ
description Many neurodegenerative diseases, including Huntington’s disease (HD) and Alzheimer’s disease (AD), occur due to an accumulation of aggregation-prone proteins, which results in neuronal death. Studies in animal and cell models show that reducing the levels of these proteins mitigates disease phenotypes. We previously reported a small molecule, NCT-504, which reduces cellular levels of mutant huntingtin (mHTT) in patient fibroblasts as well as mouse striatal and cortical neurons from an HdhQ111 mutant mouse. Here, we show that NCT-504 has a broader potential, and in addition reduces levels of Tau, a protein associated with Alzheimer’s disease, as well as other tauopathies. We find that in untreated cells, Tau and mHTT are degraded via autophagy. Notably, treatment with NCT-504 diverts these proteins to multivesicular bodies (MVB) and the ESCRT pathway. Specifically, NCT-504 causes a proliferation of endolysosomal organelles including MVB, and an enhanced association of mHTT and Tau with endosomes and MVB. Importantly, depletion of proteins that act late in the ESCRT pathway blocked NCT-504 dependent degradation of Tau. Moreover, NCT-504-mediated degradation of Tau occurred in cells where Atg7 is depleted, which indicates that this pathway is independent of canonical autophagy. Together, these studies reveal that upregulation of traffic through an ESCRT-dependent MVB pathway may provide a therapeutic approach for neurodegenerative diseases. Abbreviations: AD: Alzheimer’s disease CLEAR: Coordinated Lysosomal Expression and Regulation HTT: Huntingtin HD: Huntington’s disease MEF: Mouse embryonic fibroblasts HTT: Mutant Huntingtin MVB: Multivesicular bodies TFEB: Transcription factor EB
first_indexed 2024-03-12T00:54:50Z
format Article
id doaj.art-025cf5e3def14b5b85e8e1ea105c7f8c
institution Directory Open Access Journal
issn 2769-4127
language English
last_indexed 2024-03-12T00:54:50Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Autophagy Reports
spelling doaj.art-025cf5e3def14b5b85e8e1ea105c7f8c2023-09-14T13:24:40ZengTaylor & Francis GroupAutophagy Reports2769-41272023-12-012110.1080/27694127.2023.21667222166722Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegenerationRon Benyair0Sai Srinivas Panapakkam Giridharan1Pilar Rivero-Ríos2Junya Hasegawa3Emily Bristow4Eeva-Liisa Eskelinen5Merav D Shmueli6Vered Fishbain-Yoskovitz7Yifat Merbl8Lisa M Sharkey9Henry L. Paulson10Phyllis I Hanson11Samarjit Patnaik12Ismael Al-Ramahi13Juan Botas14Juan Marugan15Lois S. Weisman16Cell and Developmental Biology, University of Michigan, Ann Arbor, United States; Life Sciences Institute, University of MichiganCell and Developmental Biology, University of Michigan, Ann Arbor, United States; Life Sciences Institute, University of MichiganCell and Developmental Biology, University of Michigan, Ann Arbor, United States; Life Sciences Institute, University of MichiganCell and Developmental Biology, University of Michigan, Ann Arbor, United States; Life Sciences Institute, University of MichiganCell and Developmental Biology, University of Michigan, Ann Arbor, United States; Life Sciences Institute, University of MichiganInstitute of Biomedicine, University of TurkuWeizmann Institute of ScienceWeizmann Institute of ScienceWeizmann Institute of ScienceUniversity of MichiganUniversity of MichiganUniversity of Michigan School of Medicine, 1150 W. Medical Center DriveNational Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center DriveJan and Dan Duncan Neurological Research InstituteJan and Dan Duncan Neurological Research InstituteNational Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center DriveCell and Developmental Biology, University of Michigan, Ann Arbor, United States; Life Sciences Institute, University of MichiganMany neurodegenerative diseases, including Huntington’s disease (HD) and Alzheimer’s disease (AD), occur due to an accumulation of aggregation-prone proteins, which results in neuronal death. Studies in animal and cell models show that reducing the levels of these proteins mitigates disease phenotypes. We previously reported a small molecule, NCT-504, which reduces cellular levels of mutant huntingtin (mHTT) in patient fibroblasts as well as mouse striatal and cortical neurons from an HdhQ111 mutant mouse. Here, we show that NCT-504 has a broader potential, and in addition reduces levels of Tau, a protein associated with Alzheimer’s disease, as well as other tauopathies. We find that in untreated cells, Tau and mHTT are degraded via autophagy. Notably, treatment with NCT-504 diverts these proteins to multivesicular bodies (MVB) and the ESCRT pathway. Specifically, NCT-504 causes a proliferation of endolysosomal organelles including MVB, and an enhanced association of mHTT and Tau with endosomes and MVB. Importantly, depletion of proteins that act late in the ESCRT pathway blocked NCT-504 dependent degradation of Tau. Moreover, NCT-504-mediated degradation of Tau occurred in cells where Atg7 is depleted, which indicates that this pathway is independent of canonical autophagy. Together, these studies reveal that upregulation of traffic through an ESCRT-dependent MVB pathway may provide a therapeutic approach for neurodegenerative diseases. Abbreviations: AD: Alzheimer’s disease CLEAR: Coordinated Lysosomal Expression and Regulation HTT: Huntingtin HD: Huntington’s disease MEF: Mouse embryonic fibroblasts HTT: Mutant Huntingtin MVB: Multivesicular bodies TFEB: Transcription factor EBhttp://dx.doi.org/10.1080/27694127.2023.2166722escrthuntingtonhuntingtinmultivesicular bodies (mvb)nct-504neurodegenerationtau
spellingShingle Ron Benyair
Sai Srinivas Panapakkam Giridharan
Pilar Rivero-Ríos
Junya Hasegawa
Emily Bristow
Eeva-Liisa Eskelinen
Merav D Shmueli
Vered Fishbain-Yoskovitz
Yifat Merbl
Lisa M Sharkey
Henry L. Paulson
Phyllis I Hanson
Samarjit Patnaik
Ismael Al-Ramahi
Juan Botas
Juan Marugan
Lois S. Weisman
Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration
Autophagy Reports
escrt
huntington
huntingtin
multivesicular bodies (mvb)
nct-504
neurodegeneration
tau
title Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration
title_full Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration
title_fullStr Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration
title_full_unstemmed Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration
title_short Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration
title_sort upregulation of the escrt pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration
topic escrt
huntington
huntingtin
multivesicular bodies (mvb)
nct-504
neurodegeneration
tau
url http://dx.doi.org/10.1080/27694127.2023.2166722
work_keys_str_mv AT ronbenyair upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT saisrinivaspanapakkamgiridharan upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT pilarriverorios upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT junyahasegawa upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT emilybristow upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT eevaliisaeskelinen upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT meravdshmueli upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT veredfishbainyoskovitz upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT yifatmerbl upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT lisamsharkey upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT henrylpaulson upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT phyllisihanson upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT samarjitpatnaik upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT ismaelalramahi upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT juanbotas upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT juanmarugan upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration
AT loissweisman upregulationoftheescrtpathwayandmultivesicularbodiesacceleratesdegradationofproteinsassociatedwithneurodegeneration